TME-SW
01698
XIAOMI-W
01810
TRIP.COM-S
09961
BIDU-SW
09888
JD HEALTH
06618
(FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | (Q6)Dec 31, 2020 | (FY)Jun 30, 2020 | (Q6)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -6.01%42.78M | ---- | 92.01%45.52M | ---- | -93.63%23.71M | ---- | 526.19%371.99M | ---- | -79.73%59.41M | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -15.37%-65.1M | ---- | -15.86%-56.43M | ---- | 10.62%-48.7M | ---- | -13.10%-54.49M | ---- | -12.09%-48.18M | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | 93.21%-72K | ---- | 55.81%-1.06M | ---- | -82.72%-2.4M | ---- | -102.78%-1.31M | ---- |
Impairment and provisions: | -40.11%2.12M | ---- | -90.45%3.53M | ---- | 2,642.03%37.01M | ---- | -103.82%-1.46M | ---- | 137.69%38.16M | ---- |
-Impairment of property, plant and equipment (reversal) | 39.70%6.62M | ---- | -52.83%4.74M | ---- | --10.05M | ---- | ---- | ---- | ---- | ---- |
-Impairmen of inventory (reversal) | -133.75%-2.5M | ---- | -18.59%7.41M | ---- | 254.36%9.1M | ---- | -92.76%2.57M | ---- | 955.16%35.49M | ---- |
-Impairment of trade receivables (reversal) | -156.85%-830K | ---- | 241.89%1.46M | ---- | 74.43%-1.03M | ---- | -250.21%-4.02M | ---- | -78.89%2.68M | ---- |
-Other impairments and provisions | 88.32%-1.18M | ---- | -153.34%-10.08M | ---- | --18.89M | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus: | 924.97%8.21M | ---- | -68.05%801K | ---- | 116.76%2.51M | ---- | -165.76%-14.96M | ---- | 308.10%22.75M | ---- |
-Fair value of investment properties (increase) | 1,005.79%3.91M | ---- | 41.30%-432K | ---- | 95.84%-736K | ---- | -180.82%-17.7M | ---- | 855.17%21.9M | ---- |
-Other fair value changes | 248.50%4.3M | ---- | -61.98%1.23M | ---- | 18.36%3.24M | ---- | 222.73%2.74M | ---- | 110.57%849K | ---- |
Asset sale loss (gain): | 979.87%8.32M | ---- | -91.17%770K | ---- | -11.65%8.72M | ---- | -26.64%9.87M | ---- | 2.37%13.45M | ---- |
-Available for sale investment sale loss (gain) | ---- | ---- | ---- | ---- | ---114K | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---1.25M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | 133.05%5.43M | ---- | -77.79%2.33M | ---- | 6.32%10.49M | ---- | -23.87%9.87M | ---- | 8.58%12.96M | ---- |
-Loss (gain) from selling other assets | 1,015.87%2.89M | ---- | 81.01%-315K | ---- | ---1.66M | ---- | ---- | ---- | -59.27%490K | ---- |
Depreciation and amortization: | -13.47%54.11M | ---- | -31.04%62.53M | ---- | 4.96%90.69M | ---- | 1.19%86.4M | ---- | 19.07%85.38M | ---- |
Financial expense | -26.13%619K | ---- | -1.41%838K | ---- | -17.23%850K | ---- | -71.47%1.03M | ---- | -56.66%3.6M | ---- |
Special items | --1.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -28.74%53.18M | ---- |
Operating profit before the change of operating capital | -9.11%52.26M | ---- | -49.44%57.5M | ---- | -71.28%113.72M | ---- | 74.87%395.98M | ---- | -46.38%226.44M | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -21.35%42.65M | ---- | 982.16%54.23M | ---- | -84.21%5.01M | ---- | -42.33%31.74M | ---- | -22.81%55.05M | ---- |
Accounts receivable (increase)decrease | 712.68%25.36M | ---- | -103.29%-4.14M | ---- | 932.29%125.77M | ---- | -112.44%-15.11M | ---- | 264.58%121.44M | ---- |
Accounts payable increase (decrease) | 90.42%-2.19M | ---- | 61.48%-22.85M | ---- | -371.91%-59.32M | ---- | 130.34%21.82M | ---- | -200.38%-71.92M | ---- |
Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -20.53%-182K | ---- |
Cash from business operations | 39.36%118.08M | ---- | -54.24%84.73M | ---- | -57.38%185.17M | ---- | 31.31%434.42M | ---- | -34.21%330.83M | ---- |
Other taxs | 44.99%-10.21M | ---- | 60.40%-18.56M | ---- | 6.36%-46.87M | ---- | 1.41%-50.05M | ---- | 51.40%-50.76M | ---- |
Interest received - operating | 71.14%70.91M | ---- | 11.38%41.43M | ---- | -14.22%37.2M | ---- | 17.75%43.37M | ---- | -0.22%36.83M | ---- |
Special items of business | ---- | 111.03%84.28M | ---- | -74.39%39.94M | ---- | -48.72%155.92M | ---- | 51.78%304.06M | ---- | -15.28%200.34M |
Net cash from operations | 66.14%178.78M | 111.03%84.28M | -38.69%107.61M | -74.39%39.94M | -58.97%175.5M | -48.72%155.92M | 34.98%427.74M | 51.78%304.06M | -27.20%316.89M | -15.28%200.34M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -35.52%9.67M | ---- | 30.36%14.99M | ---- | 3.41%11.5M | ---- | -1.98%11.12M | ---- | 86.94%11.35M | ---- |
Dividend received - investment | ---- | ---- | 52.05%2.34M | ---- | 12.83%1.54M | ---- | --1.36M | ---- | ---- | ---- |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---2.34M | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 993.54%7.75M | ---- |
Sale of fixed assets | ---- | ---- | 3,543.36%38.4M | ---- | -83.36%1.05M | ---- | 3,648.52%6.34M | ---- | -29.58%169K | ---- |
Purchase of fixed assets | 48.20%-38.24M | ---- | 17.10%-73.82M | ---- | 6.55%-89.05M | ---- | -13.85%-95.29M | ---- | 39.62%-83.7M | ---- |
Sale of subsidiaries | ---- | ---- | --16.64M | ---- | ---- | ---- | 205.42%3.87M | ---- | ---3.67M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---84.41M | ---- | ---- | ---- |
Recovery of cash from investments | 57.43%419M | ---- | -77.56%266.15M | ---- | 63.96%1.19B | ---- | 6.77%723.28M | ---- | -73.86%677.39M | ---- |
Cash on investment | -7.47%-389.34M | ---- | 45.54%-362.28M | ---- | 53.66%-665.19M | ---- | -193.70%-1.44B | ---- | 84.37%-488.73M | ---- |
Other items in the investment business | 5.98%81.06M | 205.11%133.08M | 99.06%76.49M | -124.29%-126.61M | --38.43M | 217.36%521.3M | ---- | -584.95%-444.19M | -33.33%19.87M | 115.29%91.6M |
Net cash from investment operations | 489.72%82.16M | 205.11%133.08M | -104.38%-21.08M | -124.29%-126.61M | 155.44%481.84M | 217.36%521.3M | -718.92%-869.11M | -584.95%-444.19M | 121.73%140.42M | 115.29%91.6M |
Net cash before financing | 201.57%260.93M | 350.79%217.36M | -86.84%86.52M | -112.80%-86.67M | 248.93%657.35M | 583.28%677.22M | -196.51%-441.37M | -148.00%-140.13M | 316.88%457.32M | 180.50%291.93M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | ---- | --7.8M | ---- | ---- | ---- | -85.71%68.77M | ---- |
Refund | ---- | ---- | ---- | ---- | ---40M | ---- | ---- | ---- | 75.44%-117.38M | ---- |
Interest paid - financing | 26.13%-619K | ---- | 1.41%-838K | ---- | 17.23%-850K | ---- | 71.19%-1.03M | ---- | 51.61%-3.57M | ---- |
Dividends paid - financing | 24.90%-82.65M | ---- | -55,765.99%-110.06M | ---- | 96.31%-197K | ---- | 94.14%-5.34M | ---- | 26.52%-91.01M | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | -260.62%-9.44M | ---- | ---2.62M | ---- | ---- | ---- |
Other items of the financing business | ---- | 20.55%-85.77M | ---- | -156.80%-107.96M | ---- | -530.16%-42.04M | ---- | 95.12%-6.67M | ---- | -176.94%-136.83M |
Net cash from financing operations | 26.65%-89.55M | 20.55%-85.77M | -101.07%-122.08M | -156.80%-107.96M | -119.24%-60.71M | -530.16%-42.04M | 82.50%-27.69M | 95.12%-6.67M | -25.61%-158.22M | -176.94%-136.83M |
Effect of rate | 65.85%-4.35M | 148.01%3.99M | -15.95%-12.74M | -3,369.29%-8.3M | -136.30%-10.99M | -99.11%254K | 993.07%30.28M | 2,274.68%28.6M | 82.48%-3.39M | 80.64%-1.32M |
Net Cash | 582.04%171.39M | 167.61%131.59M | -105.96%-35.55M | -130.64%-194.62M | 227.20%596.63M | 532.68%635.18M | -256.83%-469.06M | -194.65%-146.8M | 188.80%299.1M | 183.92%155.11M |
Begining period cash | -5.75%792.2M | -5.75%792.2M | 229.79%840.5M | 229.79%840.5M | -63.26%254.86M | -63.26%254.86M | 74.31%693.64M | 64.47%693.64M | -47.23%397.93M | -44.66%421.75M |
Cash at the end | 21.08%959.23M | 45.52%927.78M | -5.75%792.2M | -28.39%637.57M | 229.79%840.5M | 54.72%890.29M | -63.26%254.86M | -0.02%575.44M | 74.31%693.64M | 0.87%575.54M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | -- | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.